Astria Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid
Astria Therapeutics, Inc. had Lessee, Operating Lease, Liability, to be Paid of $5.04 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2025-11-12
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid $5.04M.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid $5.44M.
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid $5.83M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid $6.22M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2025-09-30 | $5.04M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $5.44M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $5.83M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $6.22M 10-K · filed 2025-03-11 |
| 2024-09-30 | $6.62M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $6.88M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $171.00K 10-Q · filed 2024-05-09 |
| 2024-01-03 | $6.90M 10-Q · filed 2024-05-09 |
| 2024-01-02 | $200.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $338.00K 10-K · filed 2024-03-04 |
| 2023-09-30 | $507.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $674.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $841.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.00M 10-K · filed 2023-03-22 |
| 2022-09-30 | $1.17M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.33M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $188.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $400.00K 10-K · filed 2022-03-10 |
| 2020-12-31 | $1.12M 10-K/A · filed 2021-04-19 |
| 2020-09-30 | $1.36M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.54M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $2.08M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $2.63M 10-K · filed 2020-03-10 |
| 2019-09-30 | $1.08M 10-Q · filed 2019-11-07 |